Zum Hauptinhalt springen

Morphin ret.

06. Oktober 2024 | Morphin ret.

Navigating new norms: Addiction specialists' perspectives on opioid use disorder treatments and policy challenges in the fentanyl era.

Navigating new norms: Addiction specialists' perspectives on opioid use disorder treatments and policy challenges in the fentanyl era. Weleff J, Christian NJ, Wang JX, Singh M, De Aquino JP, Saxon AJ, Vassallo GG. Am J Addict. 2024 Oct 4. ...

01. Januar 2024 | Morphin ret.

Initiation and rapid titration of methadone and slow-release oral morphine (SROM) in an acute care, inpatient setting: a case series.

Initiation and rapid titration of methadone and slow-release oral morphine (SROM) in an acute care, inpatient setting: a case series. Rodger L, Nader M, Turner S, Lurie E. Eur J Med Res. 2023 Dec 8;28(1):573. doi: 10.1186/s40001-023-...

08. Mai 2023 | Morphin ret.

Intravenous misuse of slow-release oral morphine capsules: how much morphine is injected?

Intravenous misuse of slow-release oral morphine capsules: how much morphine is injected? Bertin C, Montigne E, Teixeira S, Ferrer F, Lauwerie L, Richard D, Authier N. Harm Reduct J. 2023 Apr 27;20(1):59. doi: 10.1186/s12954-023-0078...

09. August 2022 | Morphin ret.

Does slow release oral morphine have impact on craving and impulsivity in heroin dependent individuals?

Does slow release oral morphine have impact on craving and impulsivity in heroin dependent individuals? Giustiniani J, Rothen S, Penzenstadler L, Colombo L, Calzada G, Thorens G, Zullino D. Int Clin Psychopharmacol. 2022 Jul 14. doi:...

02. August 2022 | Morphin ret.

Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use.

Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use. Bertin C, Bezin J, Chenaf C, Delorme J, Kerckhove N, Pariente A, Tournier M, Authier N. Front Psychiatry. 2022 Jun 30;13:89...

17. August 2021 | Morphin ret.

Hydromorphone and codeine concentrations in oral fluid specimens from patients receiving substitution therapy with Substitol™ (morphine sulphate).

Hydromorphone and codeine concentrations in oral fluid specimens from patients receiving substitution therapy with Substitol™ (morphine sulphate). Lierheimer S, Beck O, Keller T, Monticelli FC, Böttcher M. Drug Test Anal. 2021 Jul 11...

17. August 2021 | Morphin ret.

Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder.

Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder. Brothers TD, Fraser J, MacAdam E, Morgan B, Webster D. Drug Alcohol Rev. 2021 Aug 4. doi: 10.1111/dar.13365. Epub ...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten